Skip to main content

Definium Therapeutics, Inc.

DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001813814

In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding Definium Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of DFTX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders191183−8
Shares41.2M41.8M+639.6K (+1.6%)
Value$240.5M$271.0M+$30.5M (+12.7%)

New holders (18)

Institutions that held Definium Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to DFTX in Q2 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC183,400$1.19M0.00%
Diadema Partners LP158,536$1.03M0.64%
StemPoint Capital LP90,852$589.6K0.19%
Persistent Asset Partners Ltd36,642$237.8K0.21%
Polar Asset Management Partners Inc.29,300$190.2K0.00%
ExodusPoint Capital Management, LP17,877$116.0K0.00%
Quantinno Capital Management LP17,154$111.3K0.00%
Dynamic Technology Lab Private Ltd14,623$95.0K0.01%
Gotham Asset Management, LLC14,078$91.4K0.00%
Mariner, LLC12,043$78.2K0.00%
Bay Rivers Group11,618$75.4K0.03%
Ameritas Advisory Services, LLC3,250$21.1K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.678$4.00K0.00%
First Pacific Financial102$6620.00%
Principal Securities, Inc.58$3760.00%
Total Investment Management Inc20$1300.00%
The PNC Financial Services Group, Inc.17$1100.00%
Essential Partners LLC4$260.00%

Sold out (26)

Institutions that held Definium Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.